Benefits
Antioxidant Properties
Green tea supplements are rich in catechins, particularly EGCG, which neutralize free radicals in laboratory assays. Some human trials also report improvements in oxidative-stress markers such as total antioxidant capacity and malondialdehyde. Whether those biomarker shifts translate into protection from age-related disease is unproven: the cited Cochrane review of green tea and cancer prevention (Filippini 2020) found the experimental and epidemiological evidence inconsistent and insufficient, and concluded green tea cannot be recommended for preventing cancer.
Weight Management Support
Catechins and caffeine in green tea may enhance metabolism and fat oxidation, modestly aiding weight loss or maintenance when combined with a healthy diet and exercise. The size of that effect is small: the cited meta-analysis of 11 studies (Hursel 2009) found catechin and caffeine mixtures produced an average of about 1.3 kg of weight loss versus control, and the benefit was noticeably weaker in people with a high habitual caffeine intake, who make up most regular coffee and tea drinkers. Green tea is a marginal add-on, not a substitute for diet, activity or an overall calorie deficit.
Cardiovascular Health
Green tea supplements may improve heart health by reducing LDL ("bad") cholesterol modestly. In the cited meta-analysis of 14 randomized trials (Zheng 2011), green tea lowered total cholesterol by roughly 7 mg/dL and LDL-C by roughly 2 mg/dL, with no change in HDL-C; pooled effects on blood pressure are similarly small, on the order of 1 to 2 mmHg. These are minor shifts in risk markers measured over weeks to months, not a demonstrated reduction in heart attacks, strokes or heart disease itself.
Cognitive Function
Most human data on focus, mood and calm alertness come from green tea as a beverage, where the combination of L-theanine and modest caffeine is the likely driver; evidence is much weaker for concentrated, often decaffeinated EGCG extracts, which supply little or none of that combination. Neuroprotective effects of EGCG remain laboratory and animal findings, and green tea is not established as a way to prevent or slow neurodegenerative disease such as Alzheimer’s, though more research is needed.
Anti-Inflammatory and Immune Support
Polyphenols in green tea have anti-inflammatory properties and may modulate immune responses, and human trials have reported reductions in inflammatory markers. This evidence is mechanistic and biomarker-level; green tea is not established as a treatment for arthritis, autoimmune conditions or any other inflammatory or immune disease, and anyone managing such a condition should work with their clinician.
Mechanism of action
Antioxidant Activity
Catechins, especially EGCG, act as potent antioxidants by scavenging free radicals and reducing oxidative stress. They inhibit reactive oxygen species (ROS) and upregulate antioxidant enzymes, protecting cells from damage linked to aging and chronic diseases.
Metabolic Enhancement for Weight Management
EGCG and caffeine stimulate thermogenesis and fat oxidation by inhibiting the enzyme catechol-O-methyltransferase (COMT), which prolongs the activity of norepinephrine, a hormone that boosts metabolism. This increases energy expenditure and fat breakdown, supporting weight loss.
Cardiovascular Benefits
Catechins improve lipid metabolism by reducing LDL cholesterol oxidation and inhibiting cholesterol absorption in the gut. They also enhance endothelial function by increasing nitric oxide production, which promotes vasodilation. These are proposed mechanisms; the effects actually measured in human trials on blood pressure and cholesterol are small.
Neuroprotective Effects
EGCG crosses the blood-brain barrier and may protect neurons by reducing oxidative stress and inflammation. L-theanine promotes alpha brain wave activity, enhancing relaxation and focus, while caffeine improves alertness by blocking adenosine receptors.
Anti-Inflammatory and Immune Modulation
Catechins inhibit pro-inflammatory pathways (e.g., NF-κB) and modulate immune cell activity, reducing inflammation and potentially enhancing immune responses. This may help manage inflammatory conditions and support overall immunity.
Clinical trials
Randomized, placebo-controlled, double-blind, parallel-group trial (NCT03628937) in Japan involving 60 healthy adults receiving combined green tea catechins + α-glucosyl hesperidin (G-Hsp) vs placebo for 12 weeks. (2021 Japanese trial)
60 healthy adults. 12-week intervention.
Combined intervention modestly reduced body fat and BMI vs placebo. Note: multi-ingredient trial — green tea-attributable effects cannot be cleanly isolated. Effects align with broader green tea catechin literature for modest weight management benefits.
Pooled analysis of 16 clinical trials (17 arms, 760 participants) evaluating green tea effects on oxidative stress markers (TAC, MDA, GPX, SOD). (2021 pooled analysis)
Pooled across 16 clinical trials, 760 participants.
Green tea significantly increased Total Antioxidant Capacity (WMD +0.20 mmol/L) and reduced malondialdehyde (lipid peroxidation marker) vs placebo. Effects more pronounced in longer interventions. Confirms catechin antioxidant mechanism translates to in vivo biomarker improvements.
Pooled analysis of 55 clinical trials (63 effect sizes) examining green tea effects on cardiovascular risk factors including lipids, blood pressure, glucose. (2023 pooled analysis)
Pooled across 55 clinical trials.
Green tea significantly reduced total cholesterol (~7 mg/dL), LDL (~4 mg/dL), systolic BP (~1-2 mmHg), and fasting glucose. Effects modest but consistent. Mechanism via EGCG-mediated effects on lipid metabolism and endothelial function. Population-level effects more meaningful than individual-level intervention.
Randomized controlled trial in 62 girls with obesity aged 6-10 receiving 400 mg/day decaffeinated green tea polyphenols vs placebo. Outcomes: anthropometrics, safety, liver function. (2024 Chinese trial)
62 obese girls aged 6-10.
Modest effects on anthropometric measures vs placebo; NO adverse effects on liver function or other safety markers in pediatric population. This trial is far too small to detect rare idiosyncratic liver injury, and concentrated green tea extract is not recommended for children.
Clinical trial in 45 women with PCOS receiving green tea tablets vs placebo for 12 weeks. Outcomes: anthropometric indices, inflammatory markers, hormonal markers. (2017)
45 women with PCOS. 12-week intervention.
Modest improvements in inflammatory markers and weight measures vs placebo. PCOS management primarily relies on lifestyle modification and metformin; green tea is at most adjunctive.
Pooled analysis of clinical trials (search through) evaluating green tea supplementation for NAFLD. Outcomes: liver enzymes, lipid profile, weight. (2018)
Pooled across NAFLD clinical trials.
Green tea modestly reduced ALT, AST, total cholesterol, and body weight in NAFLD patients vs placebo. Critical hepatotoxicity caution: this paradoxical relationship — green tea has been shown to modestly improve NAFLD markers, but high-dose green tea extracts (>800 mg EGCG/day) have been associated with rare cases of acute hepatotoxicity, sometimes severe. The 2018 EFSA report classified high-dose green tea catechins (≥800 mg EGCG/day) as potentially associated with hepatotoxicity. Most clinical trials use doses under 400 mg EGCG/day, but the USP review cited here documents liver-injury case reports from roughly 140 mg/day upward with wide individual susceptibility, so no extract dose should be assumed safe.